Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
60.92
-3.95 (-6.09%)
Mar 20, 2026, 4:00 PM EDT - Market closed

Inhibrx Biosciences Revenue

In the year 2025, Inhibrx Biosciences had annual revenue of $1.30M with 550.00% growth.

Revenue (ttm)
$1.30M
Revenue Growth
+550.00%
P/S Ratio
684.51
Revenue / Employee
$8,075
Employees
161
Market Cap
889.86M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.30M1.10M550.00%
Dec 31, 2024200.00K-1.60M-88.89%
Dec 31, 20231.80M-392.00K-17.88%
Dec 31, 20222.19M-5.04M-69.69%
Dec 31, 20217.23M-5.66M-43.89%
Dec 31, 202012.89M-323.00K-2.44%
Dec 31, 201913.21M4.62M53.71%
Dec 31, 20188.60M204.00K2.43%
Dec 31, 20178.39M1.72M25.86%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortrea Holdings2.72B
Xeris Biopharma Holdings291.85M
Valneva SE205.07M
Geron183.88M
Phathom Pharmaceuticals175.11M
Xencor125.58M
UroGen Pharma109.79M
uniQure16.10M
Revenue Rankings

INBX News

More News